These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3153612)

  • 41. [What is the present status of the common virus vaccines?].
    Regnard J
    Nouv Presse Med; 1972 Jan; 1(1):33-8. PubMed ID: 5061188
    [No Abstract]   [Full Text] [Related]  

  • 42. Towards antiviral oligopeptide vaccines.
    Niesters HG; van der Zeijst BA
    Microbiol Sci; 1984 Jun; 1(3):55-8. PubMed ID: 6086077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of recombinant DNA techniques in the development of viral vaccines.
    Murray K
    Vaccine; 1988 Apr; 6(2):164-74. PubMed ID: 3291454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interference in human viral infections: present status and prospects for the future.
    Wheelock EF; Larke RP; Caroline NL
    Prog Med Virol; 1968; 10():286-347. PubMed ID: 4304590
    [No Abstract]   [Full Text] [Related]  

  • 45. The development of a mimotope-based synthetic peptide vaccine against respiratory syncytial virus.
    Steward MW
    Biologicals; 2001; 29(3-4):215-9. PubMed ID: 11851318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New approaches in vaccine development.
    Leclerc C
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):329-41. PubMed ID: 12818620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Trends in research in developing new type of vaccines--aiming at efficacy and safety. Viral hepatitis B vaccine].
    Adachi S; Sugahara K
    Nihon Rinsho; 1987 Oct; 45(10):2427-31. PubMed ID: 3329248
    [No Abstract]   [Full Text] [Related]  

  • 48. [New technology of vaccine production--international prospect of the development. Synthetic peptide vaccines and protein engineering].
    Aimoto S; Sakiyama F
    Nihon Rinsho; 1987 Oct; 45(10):2349-54. PubMed ID: 3502349
    [No Abstract]   [Full Text] [Related]  

  • 49. Development and production aspects of a recombinant yeast-derived hepatitis B vaccine.
    Stephenne J
    Vaccine; 1990 Mar; 8 Suppl():S69-73; discussion S79-80. PubMed ID: 2139287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Designing recombinant vaccines with viral properties: a rational approach to more effective vaccines.
    Jennings GT; Bachmann MF
    Curr Mol Med; 2007 Mar; 7(2):143-55. PubMed ID: 17346167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Viral vaccines under development: a third generation.
    Osborn JE
    Adv Exp Med Biol; 1979; 118():61-82. PubMed ID: 227237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New vaccines for respiratory tract ills? Genetic engineering pursues these goals.
    Goldsmith MF
    JAMA; 1989 Oct; 262(15):2055. PubMed ID: 2677420
    [No Abstract]   [Full Text] [Related]  

  • 53. Vaccine development within industry.
    De Wilde M
    Acta Trop Suppl; 1987 Jun; 12():104-7. PubMed ID: 2957898
    [No Abstract]   [Full Text] [Related]  

  • 54. [Synthetic gene technology for new vaccines].
    Mäkelä PH
    Duodecim; 1988; 104(22):1874-80. PubMed ID: 3065068
    [No Abstract]   [Full Text] [Related]  

  • 55. Introduction to the First Clinical Vaccinology Meeting "Jean-Gérard Guillet".
    Loulergue P; Launay O
    J Clin Virol; 2009 Nov; 46(3):201. PubMed ID: 19473875
    [No Abstract]   [Full Text] [Related]  

  • 56. [The conditions for modern vaccine development].
    Murphy FA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Nov; (11):83-90. PubMed ID: 2097852
    [No Abstract]   [Full Text] [Related]  

  • 57. Vaccines in historic evolution and perspective: a narrative of vaccine discoveries.
    Hilleman MR
    Vaccine; 2000 Feb; 18(15):1436-47. PubMed ID: 10618541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Keystone in Rio: breakthroughs, predictions, and surprises.
    von Bubnoff A
    IAVI Rep; 2013; 17(4):9-13, 19. PubMed ID: 24498704
    [No Abstract]   [Full Text] [Related]  

  • 59. [Viruses to rescue health: Vaccination].
    Tangy F; Tournier JN
    Med Sci (Paris); 2022 Dec; 38(12):1052-1060. PubMed ID: 36692265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new generation of vaccines.
    Bittle JL
    Vet Clin North Am Small Anim Pract; 1986 Nov; 16(6):1247-57. PubMed ID: 3538636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.